99% Savings - Buy Just @1 Rs X
Prichek GMP 1 Tablet is a commercial drug that is prescribed in the form of Tablet. Diabetes are some of its major therapeutic uses. Secondary and off-label uses of Prichek GMP 1 Tablet have also been mentioned below.
The right dosage of Prichek GMP 1 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Prichek GMP 1 Tablet include Nausea or vomiting, Diarrhoea, Headache. Some other side effects of Prichek GMP 1 Tablet have been listed ahead. Normally, these side effects of Prichek GMP 1 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Prichek GMP 1 Tablet's effect is Unknown during pregnancy and Safe for lactating mothers. In addition, Prichek GMP 1 Tablet's effects on the liver, heart and kidney are discussed below in the Prichek GMP 1 Tablet related warnings section.
Prichek GMP 1 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Prichek GMP 1 Tablet in conditions like Liver Disease, Kidney Disease.
Drug interactions for Prichek GMP 1 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Prichek GMP 1 Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Prichek GMP 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Prichek GMP 1 Tablet safe for pregnant women?
The effects of Prichek Gmp on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Prichek GMP 1 Tablet safe during breastfeeding?
Prichek Gmp does not show any harmful effects in lactating women.
What is the effect of Prichek GMP 1 Tablet on the Kidneys?
Kidney can be affected by Prichek Gmp. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Prichek GMP 1 Tablet on the Liver?
There may be an adverse effect on the liver after taking Prichek Gmp. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Prichek GMP 1 Tablet on the Heart?
Prichek Gmp has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Prichek GMP 1 Tablet unless your doctor advises you to do so -
Is this Prichek GMP 1 Tablet habit forming or addictive?
Prichek GMP 1 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Prichek GMP 1 Tablet as you may feel sleepy.
Is it safe?
Yes, but take Prichek GMP 1 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, the use of Prichek GMP 1 Tablet in mental disorders is not effective.
Interaction between Food and Prichek GMP 1 Tablet
There isn't any research available on the side effects of taking Prichek GMP 1 Tablet with food.
Interaction between Alcohol and Prichek GMP 1 Tablet
Information about the interaction of Prichek GMP 1 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033